Salute e Benessere

The Human Change campaign launched at World Economic Forum in Davos to make…

The campaign, founded by Margarita Louis-Dreyfus, is uniting people from all walks of life –academics, paediatricians, advocates, practitioners, teachers and most importantly parents and young people – in a shared commitment to protect children from the detrimental effects of digitalization. The campaign, founded byMargarita Louis-Dreyfus, is uniting people from all walks of life –academics, paediatricians, advocates, practitioners, teachers and most importantly parents and young people – in...

Basilea announces acquisition of preclinical antibiotics program from Spexis

Novel class of antibioticsBactericidal activity demonstratedin vitroandin vivoagainst broad range of Gram-negative bacteria, including multidrug-resistant strainsAllschwil, Switzerland, January 15, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has entered into an asset purchase agreement with...

BioSenic reaches agreement on a binding term sheet with Phebra PTY Ltd. with…

PRESS RELEASE – INSIDE INFORMATION BioSenic reaches agreement on a binding term sheet with Phebra PTY Ltd. with respect to the development of the first oral formulation ofarsenic troxide for cGvHD treatmentA new binding term sheet has been signed to adapt the terms of two previous agreements under which Phebra granted Medsenic SAS, a subsidiary of BioSenic SA, an exclusive worldwide license agreement with a first marketing and distribution agreement (MDA) for OATO (oral...

BioSenic S.A. : Transparency notifications received from François Rieger

PRESS RELEASE – REGULATED INFORMATIONArticle 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, January 15, 2024, 7am CEST –BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announces that it has received transparency notifications from François Rieger that can be consulted on the website of BioSenic, under the heading “ Major shareholders...

Santhera Launches AGAMREE® (Vamorolone) in Germany as First Market for the…

AGAMREE® is the only approved medication in the European Union (EU) for treating all patients from age 4 years with DMD, and the first DMD treatment approved across the U.S., EU and UKThis marks the first commercial launch of AGAMREE® globally Pratteln, Switzerland, January 15, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces the launch of AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD) in patients 4 years of age and older, irrespective of the...

Do-it-Yourself (DIY) Home Improvement Retailing Market Size to Grow USD 979880…

Claim Your Free Sample Now: Claim Your Free Sample Now: https://reports.valuates.com/request/sample/QYRE-Auto-1M1437/Global_Do_it_Yourself_DIY_Home_Improvement_Retailing_Market_Insights_Forecast_to_2028 Major Factors Driving the Growth of Do-it-Yourself (DIY) Home Improvement Retailing Market : The Do-it-Yourself (DIY) Home Improvement Retailing Market is predicted to grow due to rising homeownership rates, a growing DIY culture that aims to customize living spaces, and an...

Amidst Ongoing Global Crises, Gates Foundation Announces Largest Annual Budget…

The foundation's $8.6 billion 2024 budget was formally approved by its board of trustees on January 13. The foundation's$8.6 billion2024 budget was formally approved by its board of trustees onJanuary 13. The budget, which represents an increase of 4% over last year and is a$2 billionincrease over the 2021 budget, comes as global contributions to health in the lowest-income countries are stalling. While overall aid spending has leveled off, sub-Saharan African countries saw a...

SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance…

BOSTON and ROLLE, Switzerland, Jan. 14, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Karkinos Healthcare, a purpose-driven cancer care technology network based in India, will partner with SOPHiA GENETICS and adopt the SOPHiA DDM™ Platform to advance cancer testing and research for blood cancers and solid tumors to underserved areas in low and middle-income countries. BOSTONand…

Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028…

Key Takeaways from the Gene Therapy Market Report Key Takeaways from the Gene Therapy Market Report To read more about the latest highlights related to the gene therapy market, get a snapshot of the key highlights entailed in theGlobal Gene Therapy Market Report Gene Therapy Overview Gene therapy is a groundbreaking medical approach aimed at treating or preventing diseases by modifying the genetic material within a person's cells. Unlike traditional treatments that focus on...

Electrolux Group reports loss in the fourth quarter - driven by North America

The main driver behind the loss in North America was intensified price pressure and weak demand during Black Friday, as well as the remainder of the year. Cost discrepancy between production located in North America compared to certain parts of Asia, as previously reported, driven by currency, raw material and inflationary impacts, has resulted in lower market price levels, particularly in refrigeration, which is a key category for business area North America. The main driver behind the loss…

Dental Implants and Prosthetics Market Worth $16.0 Billion | MarketsandMarkets™

Browse in-depth TOC on "Dental Implants and Prosthetics Market" 200 - Tables 250 - Figures 300 - Pages Browse in-depth TOC on "Dental Implants and Prosthetics Market"200 - Tables250 - Figures300 - Pages Dental Implants and Prosthetics Market Scope: § Canada • Europe § Germany § UK § France § Spain § Italy § Switzerland § Rest of Europe • Asia Pacific § China § Japan § India § South Korea ...

Ali Wong Stuns in LILYSILK Double-faced Wool-blend Robe Coat Ahead of Golden…

Inspired by the classic design of a robe coat with a contemporary spin, the Double-faced Wool-blend Robe Coat is the brainchild of a design team that prioritizes both fashion and comfort. The clean lines and premium fabric testify to LILYSILK's unwavering commitment to creating statement pieces that do not compromise on comfort or quality. Inspired by the classic design of a robe coat with a contemporary spin, the Double-faced Wool-blend Robe Coat is the brainchild of a design team that...

Groupe Casino: Very strong support from Casino Group's shareholders and…

Very strong support from Casino Group's shareholders and creditors meeting as classes of parties affected by the draft accelerated safeguard plans***Addendum*** Paris, 12 January 2024Following on from its press release on the results of the class vote, Groupe Casino points out that the rejection of the accelerated safeguard plan by one of the classes will have no impact on its implementation under the inter-class forced application mechanism. ***This press release was prepared...

IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition

Through a new amendment signed January 10, 2024, the sixth (6) payment as well as the reconciliation between the parties regarding all remaining unpaid installments has been postponed to April 15, 2024. All six installments (that remain unpaid) will incur a 15% interest charge. Failure to meet the remaining payments will result in the transfer of IMC Holdings Ltd. shares (51%) back to the seller, along with the revocation of the transaction. Through a new amendment signedJanuary 10, 2024,...

Zealand Pharma completes registration of capital increase

Company announcement – No. 3 / 2024 Zealand Pharma completes registration of capital increaseNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW.THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION EXCEPT PURSUANT TO AN EXEMPTION...

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated InformationLeuven, BELGIUM – January 12, 2024 – 8:00 AM CETOxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation 1it has received a transparency notification as follows: Oxurion received a transparency notification on January 8, 2024, from Atlas Special Opportunities, LLC indicating that as of January 3, 2024, it held 104,273,585 shares of the then outstanding...

Casino Group: Classes vote results

Very strong support from Casino Group's shareholders and creditors meeting as classes of parties affected by the draft accelerated safeguard plans Paris, 12 January 2024Aurélia Perdereau, Hélène Bourbouloux and Frédéric Abitbol, in their capacity as judicial administrators of Casino, have transmitted to Casino Group the results of the vote of all classes of affected parties on the draft accelerated safeguard plans of Casino and certain of its subsidiaries 1, details of which are set out...

Santhera Receives Approval for AGAMREE® (Vamorolone) as a Treatment for Duchenne…

Approval by the Medicines and Healthcare products Regulatory Agency (MHRA) of AGAMREE® in the United Kingdom follows marketing authorization for this medicine in the EU and U.S.MHRA acknowledges safety benefits of AGAMREE with regards to preserving bone health and maintaining growth compared to standard of care corticosteroidsLaunches of AGAMREE in Europe, with Germany taking the lead, are planned to start in Q1-2024Pratteln, Switzerland, January 12, 2024 – Santhera...

Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant…

Key Takeaways from the Gastroenteropancreatic Neuroendocrine Tumors Market Report Key Takeaways from the Gastroenteropancreatic Neuroendocrine Tumors Market Report Discover which therapies are expected to grab the major GEP-NETs market share @Gastroenteropancreatic Neuroendocrine Tumors Market Report Gastroenteropancreatic Neuroendocrine Tumors Overview Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) originate from neuroendocrine cells in the gastrointestinal tract,...

Voting Rights and Shares Capital of the Company

InaccordancewithArticlesL.233-8II oftheFrenchCommercial Codeand223-16ofthe General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)PARIS, Jan.11, 2024(GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq Euronext Compartment: B ISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website: www.nanobiotix.com DateNumber of Shares OutstandingTotal ...

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et…

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland) January 11, 2024– GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the half-year report of the liquidity contract withCrédit Industriel et Commercial. Under the liquidity contract GENFIT has withCrédit Industriel et Commercial, the following resources appeared on the...

Rising Demand for Vegan Products and Growing Vegan Population to Drive Vegan…

Request Exclusive Sample Report: Vegan Collagen Market Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-18794 Request Exclusive Sample Report: Vegan Collagen Market Strategic Insights,https://www.futuremarketinsights.com/reports/sample/rep-gb-18794 A primary driver of the vegan collagen market is the growing inclination of consumers toward functional and naturally produced components. Vegan collagen is becoming increasingly popular as people seek...

Dermal Fillers Market Size to Hit USD 8.8 Billion by 2035 | Exclusive Report by…

LONDON, Jan. 11, 2024 /PRNewswire/ -- The global dermal fillers market is estimated to be worth USD 3.1 billion in 2023 and is anticipated to reach USD 8.8 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 9.18% during the forecast period from 2023 to 2035. LONDON,Jan. 11, 2024/PRNewswire/ -- The global dermal fillers market is estimated to be worth USD 3.1 billionin 2023and is anticipated to reach USD 8.8 billionby 2035. It is expected to...

Radiation Dose Management Market Worth $654 Million | MarketsandMarkets™

Browse in-depth TOC on "Radiation Dose Management Market" Browse in-depth TOC on "Radiation Dose Management Market" 286 - Tables 35 - Figures 300 - Pages Radiation Dose Management Market Scope: Standalone solutions accounted for the larger share of the radiation dose management solution market in 2022 On the basis of product & service, the radiation dose management market is segmented into radiation dose management solutions and services. The radiation dose...

Altri Comunicati